CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis

NCT03478111 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CMAB008
DRUG: MTX
DRUG: Remicade

Sponsor

Shanghai Biomabs Pharmaceutical Co., Ltd.